@ARTICLE{
author={Muller-Quernheim Joachim,Schupp JC,Freitag-Wolf Sandra,Frye B,Zissel G,Grohe C,Mihailovic-Vucinic Violeta V,Milanowski J,Rottoli Paola,Schreiber S,Dempfle A},
year={2022},
title={Genotype-Phenotype-Relationships in Sarcoidosis},
journal={AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE},
volume={205},
number={},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={D'Haens Geert R,Reinisch Walter,Lee SD,Tarabar Dino K,Louis E,Klopocka M,Klaus J,Schreiber S,Park DI,Hebuterne Xavier,Cataldi F,Banerjee A,Gorelick K,Sandborn William J},
year={2018},
title={Long-term safety and efficacy of the anti-MAdCAM monoclonal antibody SHP647 for the treatment of Crohn's disease: the OPERA II study},
journal={JOURNAL OF CROHNS & COLITIS},
volume={12},
number={},
pages={S17-S18},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Pena-Rossi C,Schreiber S,Golubovic Gradimir,Mertz-Nielsen A,Panes J,Rachmilewitz D,Shieh MJ,Simanenkov VI,Stanton D,Graffner Hans},
year={2008},
title={Clinical trial: a multicentre, randomized, double-blind, placebo-controlled, dose-finding, phase II study of subcutaneous interferon-beta-1a in moderately active ulcerative colitis},
journal={ALIMENTARY PHARMACOLOGY & THERAPEUTICS},
volume={28},
number={6},
pages={758-767},
document_type={Article},
} 

@ARTICLE{
author={Rutgeerts P,Sandborn William J,Fedorak RN,Rachmilewitz D,Tarabar Dino K,Gibson Peter R,Nielsen OH,Wild G,Schreiber S,Rossi CP,Zignani M},
year={2006},
title={Onercept for moderate-to-severe Crohn's disease: A randomized, double-blind, placebo-controlled trial},
journal={CLINICAL GASTROENTEROLOGY AND HEPATOLOGY},
volume={4},
number={7},
pages={888-893},
document_type={Article},
}